137 related articles for article (PubMed ID: 38059302)
1. Identification of putative allosteric inhibitors of BCKDK via virtual screening and biological evaluation.
Li C; Yang Q; Zhang L
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2290458. PubMed ID: 38059302
[TBL] [Abstract][Full Text] [Related]
2. BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer.
Xue P; Zeng F; Duan Q; Xiao J; Liu L; Yuan P; Fan L; Sun H; Malyarenko OS; Lu H; Xiu R; Liu S; Shao C; Zhang J; Yan W; Wang Z; Zheng J; Zhu F
EBioMedicine; 2017 Jun; 20():50-60. PubMed ID: 28501528
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer.
Tian Q; Yuan P; Quan C; Li M; Xiao J; Zhang L; Lu H; Ma T; Zou L; Wang F; Xue P; Ni X; Wang W; Liu L; Wang Z; Zhu F; Duan Q
Oncogene; 2020 May; 39(20):3980-3996. PubMed ID: 32238881
[TBL] [Abstract][Full Text] [Related]
4. Branched-chain amino acid catabolic defect in vascular smooth muscle cells drives thoracic aortic dissection via mTOR hyperactivation.
Yu L; Huang T; Zhao J; Zhou Z; Cao Z; Chi Y; Meng S; Huang Y; Xu Y; Xia L; Jiang H; Yin Z; Wang H
Free Radic Biol Med; 2024 Jan; 210():25-41. PubMed ID: 37956909
[TBL] [Abstract][Full Text] [Related]
5. Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patients.
García-Cazorla A; Oyarzabal A; Fort J; Robles C; Castejón E; Ruiz-Sala P; Bodoy S; Merinero B; Lopez-Sala A; Dopazo J; Nunes V; Ugarte M; Artuch R; Palacín M; Rodríguez-Pombo P; Alcaide P; Navarrete R; Sanz P; Font-Llitjós M; Vilaseca MA; Ormaizabal A; Pristoupilova A; Agulló SB
Hum Mutat; 2014 Apr; 35(4):470-7. PubMed ID: 24449431
[TBL] [Abstract][Full Text] [Related]
6. Bckdk-Mediated Branch Chain Amino Acid Metabolism Reprogramming Contributes to Muscle Atrophy during Cancer Cachexia.
Chen L; Zhang H; Chi M; Wang Y; Zhu X; Han L; Xin B; Gan R; Tu Y; Sun X; Lu J; Li J; Huang J; Zhang J; Han Y; Guo C; Yang Q
Mol Nutr Food Res; 2023 Dec; ():e2300577. PubMed ID: 38150655
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of branched-chain alpha-keto acid dehydrogenase kinase augments the sensitivity of ovarian and breast cancer cells to paclitaxel.
Ibrahim SL; Abed MN; Mohamed G; Price JC; Abdullah MI; Richardson A
Br J Cancer; 2023 Mar; 128(5):896-906. PubMed ID: 36526674
[TBL] [Abstract][Full Text] [Related]
8. Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy.
Boemer F; Josse C; Luis G; Di Valentin E; Thiry J; Cello C; Caberg JH; Dadoumont C; Harvengt J; Lumaka A; Bours V; Debray FG
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216372
[TBL] [Abstract][Full Text] [Related]
9. The BCKDK inhibitor BT2 is a chemical uncoupler that lowers mitochondrial ROS production and de novo lipogenesis.
Acevedo A; Jones AE; Danna BT; Turner R; Montales KP; Benincá C; Reue K; Shirihai OS; Stiles L; Wallace M; Wang Y; Bertholet AM; Divakaruni AS
J Biol Chem; 2024 Mar; 300(3):105702. PubMed ID: 38301896
[TBL] [Abstract][Full Text] [Related]
10. Altered branched-chain α-keto acid metabolism is a feature of NAFLD in individuals with severe obesity.
Grenier-Larouche T; Coulter Kwee L; Deleye Y; Leon-Mimila P; Walejko JM; McGarrah RW; Marceau S; Trahan S; Racine C; Carpentier AC; Lusis AJ; Ilkayeva O; Vohl MC; Huertas-Vazquez A; Tchernof A; Shah SH; Newgard CB; White PJ
JCI Insight; 2022 Aug; 7(15):. PubMed ID: 35797133
[TBL] [Abstract][Full Text] [Related]
11. Loss of BCAA catabolism enhances Rab1A-mTORC1 signaling activity and promotes tumor proliferation in NSCLC.
Xue M; Xiao J; Jiang W; Wang Y; Zuo D; An H; Ren L
Transl Oncol; 2023 Aug; 34():101696. PubMed ID: 37216755
[TBL] [Abstract][Full Text] [Related]
12. Branched-chain ketoacid overload inhibits insulin action in the muscle.
Biswas D; Dao KT; Mercer A; Cowie AM; Duffley L; El Hiani Y; Kienesberger PC; Pulinilkunnil T
J Biol Chem; 2020 Nov; 295(46):15597-15621. PubMed ID: 32878988
[TBL] [Abstract][Full Text] [Related]
13. Branched-Chain Amino Acid Catabolism Promotes Thrombosis Risk by Enhancing Tropomodulin-3 Propionylation in Platelets.
Xu Y; Jiang H; Li L; Chen F; Liu Y; Zhou M; Wang J; Jiang J; Li X; Fan X; Zhang L; Zhang J; Qiu J; Wu Y; Fang C; Sun H; Liu J
Circulation; 2020 Jul; 142(1):49-64. PubMed ID: 32200651
[TBL] [Abstract][Full Text] [Related]
14. BCKDK alters the metabolism of non-small cell lung cancer.
Wang Y; Xiao J; Jiang W; Zuo D; Wang X; Jin Y; Qiao L; An H; Yang L; Dumoulin DW; Dempke WCM; Best SA; Ren L
Transl Lung Cancer Res; 2021 Dec; 10(12):4459-4476. PubMed ID: 35070754
[TBL] [Abstract][Full Text] [Related]
15. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.
Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D
Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704
[TBL] [Abstract][Full Text] [Related]
16. Divergent Induction of Branched-Chain Aminotransferases and Phosphorylation of Branched Chain Keto-Acid Dehydrogenase Is a Potential Mechanism Coupling Branched-Chain Keto-Acid-Mediated-Astrocyte Activation to Branched-Chain Amino Acid Depletion-Mediated Cognitive Deficit after Traumatic Brain Injury.
Xing G; Ren M; Verma A
J Neurotrauma; 2018 Oct; 35(20):2482-2494. PubMed ID: 29764289
[TBL] [Abstract][Full Text] [Related]
17. Partial suppression of BCAA catabolism as a potential therapy for BCKDK deficiency.
Ohl L; Kuhs A; Pluck R; Durham E; Noji M; Philip ND; Arany Z; Ahrens-Nicklas RC
Mol Genet Metab Rep; 2024 Jun; 39():101091. PubMed ID: 38770403
[TBL] [Abstract][Full Text] [Related]
18. A molecular model of human branched-chain amino acid metabolism.
Suryawan A; Hawes JW; Harris RA; Shimomura Y; Jenkins AE; Hutson SM
Am J Clin Nutr; 1998 Jul; 68(1):72-81. PubMed ID: 9665099
[TBL] [Abstract][Full Text] [Related]
19. BCKDK modification enhances the anticancer efficacy of CAR-T cells by reprogramming branched chain amino acid metabolism.
Yang Q; Zhu X; Huang P; Li C; Han L; Han Y; Gan R; Xin B; Tu Y; Zhou S; Yuan T; Hao J; Li C; Zhang L; Shi L; Guo C
Mol Ther; 2024 May; ():. PubMed ID: 38734897
[TBL] [Abstract][Full Text] [Related]
20. A Gain-of-Function Mutation on
Maguolo A; Rodella G; Giorgetti A; Nicolodi M; Ribeiro R; Dianin A; Cantalupo G; Monge I; Carcereri S; De Bernardi ML; Delledonne M; Pasini A; Campostrini N; Ion Popa F; Piacentini G; Teofoli F; Vincenzi M; Camilot M; Bordugo A
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
